Efficacy evaluation of contrast-enhanced magnetic resonance imaging in differentiating glioma from metastatic tumor of the brain and exploration of its association with patients’ neurological function

Objective: To determine the efficacy of contrast-enhanced MRI in differentiating gliomas (GL) from metastatic tumor of the brain (MTB) and its association with patients’ neurological function. Methods: Admitted between April 2019 and January 2022, 49 patients with pathologically confirmed GL and 42...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in behavioral neuroscience Vol. 16; p. 957795
Main Authors Shi, Zhuo, Jiang, Jiuming, Xie, Lizhi, Zhao, Xinming
Format Journal Article
LanguageEnglish
Published Lausanne Frontiers Research Foundation 06.09.2022
Frontiers Media S.A
Subjects
Online AccessGet full text
ISSN1662-5153
1662-5153
DOI10.3389/fnbeh.2022.957795

Cover

Loading…
Abstract Objective: To determine the efficacy of contrast-enhanced MRI in differentiating gliomas (GL) from metastatic tumor of the brain (MTB) and its association with patients’ neurological function. Methods: Admitted between April 2019 and January 2022, 49 patients with pathologically confirmed GL and 42 cases with MTB were selected as the subjects for retrospective analysis. All patients were examined by a set of MRI sequences that included T1WI, T2WI, FLAIR, and DWI. The values of fractional anisotropy (FA), apparent diffusion coefficient (ADC) and operation coefficient (Ktrans) were calculated by taking the tumor parenchyma area, cystic area and peritumor edema area as the regions of interest (ROIs). And according to the Mini-mental State Examination (MMSE) results, the contrast-enhanced MRI with patients’ neurological dysfunction was observed. Results: The clinical symptoms and MRI findings of MTB and GL were basically the same, mainly showing neurological symptoms. The tumor parenchyma area and cystic area were mainly located in the tumor periphery and tumor central area, respectively, while the peritumor edema area was widely distributed, showing an irregular patchy edema zone. Contrast-enhanced scans suggested obvious enhancement in the tumor parenchymal area, presenting with nodular and annular enhancement, but no enhancement in the tumor cystic and peritumor edema areas. There was no difference between GL and MTB in FA values of tumor cystic area and peritumor edema area (P>0.05), but the FA value of the parenchyma area of GL was higher (P0.05), while the former presented lower ADC values and higher Ktrans values of the peritumor edema area than the latter (P<0.05). In GL and MTB patients, the FA and Ktrans values of all ROIs in those with neurological dysfunction were higher compared with those without neurological dysfunction, while the ADC values were lower (P<0.05). Conclusion: Contrast-enhanced MRI of peritumor edema area can effectively distinguish GL from MTB, and improve the accuracy of early clinical screening, thus providing more reliable life security for patients.
AbstractList ObjectiveTo determine the efficacy of contrast-enhanced MRI in differentiating glioma (GL) from the metastatic tumor of the brain (MTB) and its association with patients’ neurological function.MethodsA retrospective analysis was conducted on 49 cases of pathologically confirmed GL and 42 cases of MTB admitted between April 2019 and January 2022. All patients were examined by a set of MRI sequences that included T1WI, T2WI, FLAIR, and DWI. The values of fractional anisotropy (FA), apparent diffusion coefficient (ADC), and operation coefficient (Ktrans) were calculated by taking the tumor parenchyma area, cystic area, and peritumor edema area as the regions of interest (ROIs). And according to the Mini-mental state examination (MMSE) results, the contrast-enhanced MRI with patients’ neurological dysfunction was observed.ResultsThe clinical symptoms and MRI findings of MTB and GL were basically the same, mainly showing neurological symptoms. The tumor parenchyma area and cystic area were mainly located in the tumor periphery and tumor central area, respectively, while the peritumor edema area was widely distributed, showing an irregular patchy edema zone. Contrast-enhanced scans suggested an obvious enhancement in the tumor parenchymal area, presenting with nodular and annular enhancement, but no enhancement in the tumor cystic and peritumor edema areas. There was no difference between GL and MTB in FA values of tumor cystic area and peritumor edema area (P > 0.05), but the FA value of the parenchyma area of GL was higher (P < 0.05). Besides, GL and MTB showed no difference in ADC and Ktrans values (P > 0.05), while the former presented lower ADC values and higher Ktrans values of the peritumor edema area than the latter (P < 0.05). In patients with GL and MTB, the FA and Ktrans values of all ROIs in those with neurological dysfunction were higher compared with those without neurological dysfunction, while the ADC values were lower (P < 0.05).ConclusionContrast-enhanced MRI of peritumor edema area can effectively distinguish GL from MTB, and improve the accuracy of early clinical screening, thus providing more reliable life security for patients.
To determine the efficacy of contrast-enhanced MRI in differentiating glioma (GL) from the metastatic tumor of the brain (MTB) and its association with patients' neurological function.ObjectiveTo determine the efficacy of contrast-enhanced MRI in differentiating glioma (GL) from the metastatic tumor of the brain (MTB) and its association with patients' neurological function.A retrospective analysis was conducted on 49 cases of pathologically confirmed GL and 42 cases of MTB admitted between April 2019 and January 2022. All patients were examined by a set of MRI sequences that included T1WI, T2WI, FLAIR, and DWI. The values of fractional anisotropy (FA), apparent diffusion coefficient (ADC), and operation coefficient (Ktrans) were calculated by taking the tumor parenchyma area, cystic area, and peritumor edema area as the regions of interest (ROIs). And according to the Mini-mental state examination (MMSE) results, the contrast-enhanced MRI with patients' neurological dysfunction was observed.MethodsA retrospective analysis was conducted on 49 cases of pathologically confirmed GL and 42 cases of MTB admitted between April 2019 and January 2022. All patients were examined by a set of MRI sequences that included T1WI, T2WI, FLAIR, and DWI. The values of fractional anisotropy (FA), apparent diffusion coefficient (ADC), and operation coefficient (Ktrans) were calculated by taking the tumor parenchyma area, cystic area, and peritumor edema area as the regions of interest (ROIs). And according to the Mini-mental state examination (MMSE) results, the contrast-enhanced MRI with patients' neurological dysfunction was observed.The clinical symptoms and MRI findings of MTB and GL were basically the same, mainly showing neurological symptoms. The tumor parenchyma area and cystic area were mainly located in the tumor periphery and tumor central area, respectively, while the peritumor edema area was widely distributed, showing an irregular patchy edema zone. Contrast-enhanced scans suggested an obvious enhancement in the tumor parenchymal area, presenting with nodular and annular enhancement, but no enhancement in the tumor cystic and peritumor edema areas. There was no difference between GL and MTB in FA values of tumor cystic area and peritumor edema area (P > 0.05), but the FA value of the parenchyma area of GL was higher (P < 0.05). Besides, GL and MTB showed no difference in ADC and Ktrans values (P > 0.05), while the former presented lower ADC values and higher Ktrans values of the peritumor edema area than the latter (P < 0.05). In patients with GL and MTB, the FA and Ktrans values of all ROIs in those with neurological dysfunction were higher compared with those without neurological dysfunction, while the ADC values were lower (P < 0.05).ResultsThe clinical symptoms and MRI findings of MTB and GL were basically the same, mainly showing neurological symptoms. The tumor parenchyma area and cystic area were mainly located in the tumor periphery and tumor central area, respectively, while the peritumor edema area was widely distributed, showing an irregular patchy edema zone. Contrast-enhanced scans suggested an obvious enhancement in the tumor parenchymal area, presenting with nodular and annular enhancement, but no enhancement in the tumor cystic and peritumor edema areas. There was no difference between GL and MTB in FA values of tumor cystic area and peritumor edema area (P > 0.05), but the FA value of the parenchyma area of GL was higher (P < 0.05). Besides, GL and MTB showed no difference in ADC and Ktrans values (P > 0.05), while the former presented lower ADC values and higher Ktrans values of the peritumor edema area than the latter (P < 0.05). In patients with GL and MTB, the FA and Ktrans values of all ROIs in those with neurological dysfunction were higher compared with those without neurological dysfunction, while the ADC values were lower (P < 0.05).Contrast-enhanced MRI of peritumor edema area can effectively distinguish GL from MTB, and improve the accuracy of early clinical screening, thus providing more reliable life security for patients.ConclusionContrast-enhanced MRI of peritumor edema area can effectively distinguish GL from MTB, and improve the accuracy of early clinical screening, thus providing more reliable life security for patients.
Objective: To determine the efficacy of contrast-enhanced MRI in differentiating gliomas (GL) from metastatic tumor of the brain (MTB) and its association with patients’ neurological function. Methods: Admitted between April 2019 and January 2022, 49 patients with pathologically confirmed GL and 42 cases with MTB were selected as the subjects for retrospective analysis. All patients were examined by a set of MRI sequences that included T1WI, T2WI, FLAIR, and DWI. The values of fractional anisotropy (FA), apparent diffusion coefficient (ADC) and operation coefficient (Ktrans) were calculated by taking the tumor parenchyma area, cystic area and peritumor edema area as the regions of interest (ROIs). And according to the Mini-mental State Examination (MMSE) results, the contrast-enhanced MRI with patients’ neurological dysfunction was observed. Results: The clinical symptoms and MRI findings of MTB and GL were basically the same, mainly showing neurological symptoms. The tumor parenchyma area and cystic area were mainly located in the tumor periphery and tumor central area, respectively, while the peritumor edema area was widely distributed, showing an irregular patchy edema zone. Contrast-enhanced scans suggested obvious enhancement in the tumor parenchymal area, presenting with nodular and annular enhancement, but no enhancement in the tumor cystic and peritumor edema areas. There was no difference between GL and MTB in FA values of tumor cystic area and peritumor edema area (P>0.05), but the FA value of the parenchyma area of GL was higher (P0.05), while the former presented lower ADC values and higher Ktrans values of the peritumor edema area than the latter (P<0.05). In GL and MTB patients, the FA and Ktrans values of all ROIs in those with neurological dysfunction were higher compared with those without neurological dysfunction, while the ADC values were lower (P<0.05). Conclusion: Contrast-enhanced MRI of peritumor edema area can effectively distinguish GL from MTB, and improve the accuracy of early clinical screening, thus providing more reliable life security for patients.
Author Xie, Lizhi
Shi, Zhuo
Zhao, Xinming
Jiang, Jiuming
AuthorAffiliation 1 Department of Imaging Diagnosis, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing , China
2 GE Healthcare, MR Research China , Beijing , China
AuthorAffiliation_xml – name: 2 GE Healthcare, MR Research China , Beijing , China
– name: 1 Department of Imaging Diagnosis, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing , China
Author_xml – sequence: 1
  givenname: Zhuo
  surname: Shi
  fullname: Shi, Zhuo
– sequence: 2
  givenname: Jiuming
  surname: Jiang
  fullname: Jiang, Jiuming
– sequence: 3
  givenname: Lizhi
  surname: Xie
  fullname: Xie, Lizhi
– sequence: 4
  givenname: Xinming
  surname: Zhao
  fullname: Zhao, Xinming
BookMark eNp1ks1u1DAUhSNUJNrCA7CzxIZNBsfxT7JBQlWBSpXYwNpy7OuMR4k92E6hu74Gr8Rj8CQ4MwXRSqxsHZ_zXfv6nlUnPnioqpcN3rRt17-xfoDthmBCNj0TomdPqtOGc1KzhrUn_-yfVWcp7TDmhFNxWv28tNZppW8R3KhpUdkFj4JFOvgcVco1-K3yGgya1eghO40ipOBXDbmiOT8i55Fx1kIEn11BFGmcXJgVsjHMaIZcSGrN5mUOceXnLaAhqpJU3iD4vp9C_Fvc5YRUSkG7o_TN5S3al33hp193P5CHJYYpjOXmE7KL16vtefXUqinBi_v1vPry_vLzxcf6-tOHq4t317WmAudaWdFwRoduMAO3RmPgoCllbGh5RzTRdmAN7wTtTGNUb5u24bQ3nSCWMsxMe15dHbkmqJ3cx9KFeCuDcvIghDhKFctjJ5Cacm257kjfctoNTPXadm1viOWUM6sK6-2RtV-GGYyGtevTA-jDE--2cgw3sqcdxz0pgNf3gBi-LpCynF3SME3KQ1iSJKIRvJTkolhfPbLuwhJ9adXqwphwJnhxiaNLx5BSBCu1y4dvKPXdJBss14GTh4GT68DJ48CVZPMo-ecZ_8_8Bn5L5Lk
CitedBy_id crossref_primary_10_1016_j_acra_2024_06_006
crossref_primary_10_1007_s10278_024_01026_9
crossref_primary_10_13104_imri_2022_26_4_256
Cites_doi 10.1007/s00330-019-06548-3
10.1016/j.nucmedbio.2021.02.003
10.1002/jmri.26611
10.1016/j.nec.2018.08.008
10.1111/jon.12281
10.1126/scitranslmed.aba2591
10.1016/j.jocn.2020.04.051
10.1038/s41598-021-90032-w
10.1186/s13014-019-1228-x
10.18632/oncotarget.11114
10.2174/1573405617666210316120314
10.12968/hmed.2019.80.7.380
10.2463/mrms.2014-0129
10.1016/j.wneu.2020.09.113
10.1016/j.semcancer.2017.11.010
10.1186/s12880-020-00488-x
10.23736/S0390-5616.20.05112-7
10.1016/j.canlet.2020.02.025
10.1007/s11060-020-03499-4
10.1038/s41582-021-00510-y
10.1158/2159-8290.CD-20-1474
10.1016/j.canlet.2020.02.002
ContentType Journal Article
Copyright 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright © 2022 Shi, Jiang, Xie and Zhao.
Copyright © 2022 Shi, Jiang, Xie and Zhao. 2022 Shi, Jiang, Xie and Zhao
Copyright_xml – notice: 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Copyright © 2022 Shi, Jiang, Xie and Zhao.
– notice: Copyright © 2022 Shi, Jiang, Xie and Zhao. 2022 Shi, Jiang, Xie and Zhao
DBID AAYXX
CITATION
3V.
7QG
7QP
7QR
7TK
7XB
88I
8FD
8FE
8FH
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FR3
GNUQQ
HCIFZ
LK8
M2P
M7P
P64
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PSYQQ
Q9U
7X8
5PM
DOA
DOI 10.3389/fnbeh.2022.957795
DatabaseName CrossRef
ProQuest Central (Corporate)
Animal Behavior Abstracts
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Neurosciences Abstracts
ProQuest Central (purchase pre-March 2016)
Science Database (Alumni Edition)
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central Korea
Engineering Research Database
ProQuest Central Student
SciTech Premium Collection
ProQuest Biological Science Collection
Science Database (ProQuest)
Biological Science Database (ProQuest)
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
Publicly Available Content Database
ProQuest One Psychology
ProQuest Central Student
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central
ProQuest One Applied & Life Sciences
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
Chemoreception Abstracts
ProQuest Central (New)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
ProQuest One Academic UKI Edition
Animal Behavior Abstracts
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 1662-5153
ExternalDocumentID oai_doaj_org_article_c46cf6c8293648b5a9cf839d2f6465fa
PMC9486092
10_3389_fnbeh_2022_957795
GroupedDBID ---
29H
2WC
53G
5GY
5VS
8FE
8FH
9T4
AAFWJ
AAYXX
ABIVO
ABUWG
ACGFO
ACGFS
ACIWK
ACPRK
ACXDI
ADBBV
ADRAZ
AEGXH
AENEX
AFKRA
AFPKN
AIAGR
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
CITATION
CS3
DIK
E3Z
EMOBN
F5P
GROUPED_DOAJ
GX1
HCIFZ
HYE
KQ8
LK8
M2P
M48
M7P
M~E
O5R
O5S
OK1
OVT
PGMZT
PIMPY
PQQKQ
PROAC
PSYQQ
RNS
RPM
TR2
3V.
7QG
7QP
7QR
7TK
7XB
88I
8FD
8FK
CCPQU
DWQXO
FR3
GNUQQ
P64
PHGZM
PHGZT
PKEHL
PQEST
PQGLB
PQUKI
Q9U
7X8
5PM
ID FETCH-LOGICAL-c470t-af71654b8bdb6fdc0e6ec4455b3682c2cfb5168748d1da9f131649d872f4505d3
IEDL.DBID M48
ISSN 1662-5153
IngestDate Wed Aug 27 01:32:55 EDT 2025
Thu Aug 21 18:39:59 EDT 2025
Fri Jul 11 12:16:54 EDT 2025
Mon Jun 30 09:38:10 EDT 2025
Tue Jul 01 01:14:13 EDT 2025
Thu Apr 24 23:01:08 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c470t-af71654b8bdb6fdc0e6ec4455b3682c2cfb5168748d1da9f131649d872f4505d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Reviewed by: Fenglong Sun, Capital University of Medical Sciences, China; Yang Liu, The First Medical Center of Chinese PLA General Hospital, China
This article was submitted to Emotion Regulation and Processing, a section of the journal Frontiers in Behavioral Neuroscience
Edited by: Fenglin Liu, Korea University of Technology and Education, South Korea
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fnbeh.2022.957795
PQID 2710026576
PQPubID 2046456
ParticipantIDs doaj_primary_oai_doaj_org_article_c46cf6c8293648b5a9cf839d2f6465fa
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9486092
proquest_miscellaneous_2717683967
proquest_journals_2710026576
crossref_citationtrail_10_3389_fnbeh_2022_957795
crossref_primary_10_3389_fnbeh_2022_957795
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-09-06
PublicationDateYYYYMMDD 2022-09-06
PublicationDate_xml – month: 09
  year: 2022
  text: 2022-09-06
  day: 06
PublicationDecade 2020
PublicationPlace Lausanne
PublicationPlace_xml – name: Lausanne
PublicationTitle Frontiers in behavioral neuroscience
PublicationYear 2022
Publisher Frontiers Research Foundation
Frontiers Media S.A
Publisher_xml – name: Frontiers Research Foundation
– name: Frontiers Media S.A
References Priya (B16) 2021; 11
Majigsuren (B13) 2016; 15
Nicholson (B15) 2021; 11
Tsiouris (B20) 2019; 22
Mueller (B14) 2020
Almansory (B2) 2019; 80
Li (B12) 2020; 20
Smits (B18) 2021; 17
Gusyatiner (B6) 2018; 51
Tepe (B19) 2021; 17
Abecassis (B1) 2020; 76
Harisinghani (B7) 2019; 11
Hu (B8) 2020; 477
Vallejo-Armenta (B21) 2021
Gannon (B4) 2019; 49
Kim (B11) 2020; 30
Furuse (B3) 2019; 14
Xu (B23) 2020; 476
Przybylowski (B17) 2021; 151
Jin (B9) 2021; 149
Jung (B10) 2016; 26
Gao (B5) 2016; 7
Wang (B22) 2019; 30
References_xml – volume: 30
  start-page: 2142
  year: 2020
  ident: B11
  article-title: Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma.
  publication-title: Eur. Radiol.
  doi: 10.1007/s00330-019-06548-3
– start-page: 1
  year: 2021
  ident: B21
  article-title: [(99m)Tc]Tc-iPSMA SPECT brain imaging as a potential specific diagnosis of metastatic brain tumors and high-grade gliomas.
  publication-title: Nuclear Med. Biol.
  doi: 10.1016/j.nucmedbio.2021.02.003
– volume: 49
  start-page: e122
  year: 2019
  ident: B4
  article-title: State of the art: Evaluation and prognostication of myocarditis using cardiac MRI.
  publication-title: J. Magn. Reson. Imaging
  doi: 10.1002/jmri.26611
– volume: 30
  start-page: 111
  year: 2019
  ident: B22
  article-title: Low-grade glioma radiotherapy treatment and trials.
  publication-title: Neurosurg. Clin. N. Am.
  doi: 10.1016/j.nec.2018.08.008
– volume: 26
  start-page: 240
  year: 2016
  ident: B10
  article-title: Comparison of glioblastomas and brain metastases using dynamic contrast-enhanced perfusion MRI.
  publication-title: J. Neuroimaging.
  doi: 10.1111/jon.12281
– volume: 11
  year: 2019
  ident: B7
  article-title: Advances in clinical MRI technology.
  publication-title: Sci. Transl. Med.
  doi: 10.1126/scitranslmed.aba2591
– volume: 76
  start-page: 46
  year: 2020
  ident: B1
  article-title: Evaluating angioarchitectural characteristics of glial and metastatic brain tumors with conventional magnetic resonance imaging.
  publication-title: J. Clin. Neurosci.
  doi: 10.1016/j.jocn.2020.04.051
– volume: 11
  year: 2021
  ident: B16
  article-title: Machine learning based differentiation of glioblastoma from brain metastasis using MRI derived radiomics.
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-021-90032-w
– volume: 14
  year: 2019
  ident: B3
  article-title: Radiological diagnosis of brain radiation necrosis after cranial irradiation for brain tumor: A systematic review.
  publication-title: Radiat. Oncol.
  doi: 10.1186/s13014-019-1228-x
– volume: 7
  start-page: 71330
  year: 2016
  ident: B5
  article-title: Circulating tumor cell is a common property of brain glioma and promotes the monitoring system.
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.11114
– volume: 17
  start-page: 1200
  year: 2021
  ident: B19
  article-title: The potential role of peritumoral apparent diffusion coefficient evaluation in differentiating glioblastoma and solitary metastatic lesions of the brain.
  publication-title: Curr. Med. Imaging
  doi: 10.2174/1573405617666210316120314
– volume: 80
  start-page: 380
  year: 2019
  ident: B2
  article-title: Combined PET/MRI in brain glioma imaging.
  publication-title: Br. J. Hosp. Med. (Lond)
  doi: 10.12968/hmed.2019.80.7.380
– volume: 15
  start-page: 34
  year: 2016
  ident: B13
  article-title: Comparison of brain tumor contrast-enhancement on T1-CUBE and 3D-SPGR images.
  publication-title: Magn. Reson. Med. Sci.
  doi: 10.2463/mrms.2014-0129
– volume: 149
  start-page: 325
  year: 2021
  ident: B9
  article-title: Brain glioma localization diagnosis based on magnetic resonance imaging.
  publication-title: World Neurosurg.
  doi: 10.1016/j.wneu.2020.09.113
– volume: 51
  start-page: 50
  year: 2018
  ident: B6
  article-title: Glioma epigenetics: From subclassification to novel treatment options.
  publication-title: Semin. Cancer Biol.
  doi: 10.1016/j.semcancer.2017.11.010
– volume: 20
  year: 2020
  ident: B12
  article-title: Solitary vertebral metastatic glioblastoma in the absence of primary brain tumor relapse: A case report and literature review.
  publication-title: BMC Med. Imaging
  doi: 10.1186/s12880-020-00488-x
– year: 2020
  ident: B14
  article-title: Enzymatic activity of extracellular circulating proteasome in the CSF of patients with malignant intrinsic and metastatic brain tumors: Proof of concept.
  publication-title: J. Neurosurg. Sci.
  doi: 10.23736/S0390-5616.20.05112-7
– volume: 22
  start-page: 206
  year: 2019
  ident: B20
  article-title: Principles and current trends in the correlative evaluation of glioma with advanced MRI techniques and PET.
  publication-title: Hell. J. Nuclear Med.
– volume: 477
  start-page: 97
  year: 2020
  ident: B8
  article-title: Imaging of intratumoral heterogeneity in high-grade glioma.
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2020.02.025
– volume: 151
  start-page: 491
  year: 2021
  ident: B17
  article-title: Surgical strategy for insular glioma.
  publication-title: J. Neurooncol.
  doi: 10.1007/s11060-020-03499-4
– volume: 17
  start-page: 486
  year: 2021
  ident: B18
  article-title: MRI biomarkers in neuro-oncology.
  publication-title: Nat. Rev. Neurol.
  doi: 10.1038/s41582-021-00510-y
– volume: 11
  start-page: 575
  year: 2021
  ident: B15
  article-title: Diffuse glioma heterogeneity and its therapeutic implications.
  publication-title: Cancer Discov.
  doi: 10.1158/2159-8290.CD-20-1474
– volume: 476
  start-page: 1
  year: 2020
  ident: B23
  article-title: Immunotherapy for glioma: Current management and future application.
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2020.02.002
SSID ssj0062647
Score 2.315352
Snippet Objective: To determine the efficacy of contrast-enhanced MRI in differentiating gliomas (GL) from metastatic tumor of the brain (MTB) and its association with...
To determine the efficacy of contrast-enhanced MRI in differentiating glioma (GL) from the metastatic tumor of the brain (MTB) and its association with...
ObjectiveTo determine the efficacy of contrast-enhanced MRI in differentiating glioma (GL) from the metastatic tumor of the brain (MTB) and its association...
SourceID doaj
pubmedcentral
proquest
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
StartPage 957795
SubjectTerms Anisotropy
apparent diffusion coefficient
Brain tumors
Diffusion coefficient
Disease
Edema
fractional anisotropy
Glioma
Ktrans
Magnetic resonance imaging
Metastases
Metastasis
metastatic tumor of brain
MRI
Neuroimaging
Neurological complications
Neuroscience
Parenchyma
Patients
Tumors
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELZQT1wQUBCBggYJcUAKzTqOnRwLalUhwYlKvUX-bVdqHNTNHnrra_BKPEafpDNOdru5wIVLDomdOJ6J55t45hvGPihXCGJtyW0hNaXkqNyEssJDUbi69Non2sXvP-Tpmfh2Xp3vlPqimLCRHnicuEMrpA3S1miWpKhNpRsb0Kg7HqSQVUjQCG3expka12BE6UKNe5jogjWHIRpPOw-cf24qpaiYxI4VSmT9M4Q5j4_cMTgnT9mTCSnC0TjCZ-yRj8_Z_lFEL7m7gY-QYjfTT_F99ueYmCC0vYEH9m7oA6RAdL0ach8v01Y_dPoiUt4ioJvdE9mGh2WXKhXBMsKmXMpAAsNTF1fLvtNAOSjQ-UFT-hH2HdZdf033R_QIhopMgI4OfIrn2z58OaxAP0gf6JcvTDyuq7vb35C4NKe1F8jAUrMX7Ozk-OfX03yq0pBboYoh10FRRpSpDWX0OVt46a0QVWVKWXPLbTDVQtZK1G7hdBMWJXpojasVDwLhlytfsr3YR_-KQW1LAniWE7ArtDGuqApuZSO5VghcMlZspNbaicKcKmlctejKkKDbJOiWBN2Ogs7Yp22XXyN_x98afyFV2DYk6u10AhWynRSy_ZdCZuxgo0jttB6sWk4kSlyic5ex99vL-CXT9oyOvl-nNuj7lY1UGVMzBZwNaH4lLi8TJ3hDxcQa_vp_vMEb9pgmJUXSyQO2N1yv_VuEXoN5l76ye61aNYo
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NbtQwELagvXBBQEEsFDRIiANSaNZx7OSEWrRVhUSFEJV6i_y7jdQ4ZTd76I3X4JV4DJ4Ej9e721x6ySFx_jTj8TeemW8IeS9MzpC1JdM5l1iSIzLlijIc8txUhZU20i5-O-dnF-zrZXmZNtyWKa1yYxOjoTa9xj3yI4o0NJQHePz55leGXaMwuppaaDwk-8EEV8H52j-ZnX__sbHFAa0zsY5lBlesPnJeWYxAUPqpLoXAphJ3VqNI2j9CmuM8yTsLz-kT8jghRjhei_gpeWD9M3Jw7IO33N3CB4g5nHFz_ID8nSEjhNS3sGPxht5BTEiXyyGz_iqG_KGTc4_1ixDc7R5JNyy0XexYBK2HTduUAQUXTs2v276TgLUo0NlBYhlSuHdYdf0Cnx9QJChsNgHSG7Axr2_78nZYgtxpAeDWLyQ-1-W_338gcmomGwy40OKw5-TidPbzy1mWujVkmol8yKQTWBmlKoWVfUbnllvNWFmqgldUU-1UOeWVYJWZGlm7aRE8tdpUgjoWYJgpXpA933v7kkClCwR6miLAy6VSJi9zqnnNqRQBwExIvpFaoxOVOXbUuG6CS4OCbqKgGxR0sxb0hHzc3nKz5vG4b_AJqsJ2IFJwxxP9Yt6kGd1oxrXjugp4ibNKlbLWLqBNQx1nvHRyQg43itQku7Bsdlo8Ie-2l8OMxjCN9LZfxTHBByxqLiZEjBRw9EHjK769itzgNTYVq-mr-1_-mjzC3425cvyQ7A2LlX0TwNWg3qYZ9B8Zey4V
  priority: 102
  providerName: ProQuest
Title Efficacy evaluation of contrast-enhanced magnetic resonance imaging in differentiating glioma from metastatic tumor of the brain and exploration of its association with patients’ neurological function
URI https://www.proquest.com/docview/2710026576
https://www.proquest.com/docview/2717683967
https://pubmed.ncbi.nlm.nih.gov/PMC9486092
https://doaj.org/article/c46cf6c8293648b5a9cf839d2f6465fa
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Rb9MwELbG9sILGgxEYVSHhHhAykgdx04eENpQx4S0CSEq9S2yHbuL1DjQptL6xt_gL_Ez-CX43LQj0sQDL3lI7LbK3fW-8919R8grUcYMWVsiHXOJLTkiUjZJ_SWOyywx0gTaxcsrfjFhn6bpdI9sx1t1L3B5Z2iH86Qmi_nJzff1e2_w7zDi9P72rXXKYF6B0pM8FSJP75ED75gE2ukl2yUVPHRnYpPYvHtbzzUFBv8e7OwXTf7lhc4PyYMOPsLpRt4PyZ5xj8jRqfOhc72G1xAKOsNJ-RH5NUZ6CKnXcEvpDY2FUJ0ul21k3HXI_0MtZw6bGcHH3g0ycBio6jC-CCoH2xkqLUrR35rNq6aWgI0pUJtWYk-S39uu6maBn-8hJSicPAHSlWBCkd_uy6t2CfJWJQDPgaEjd13-_vETAsFm94cM6HVx2WMyOR9__XARdaMbIs1E3EbSCmyTUpnCNr9Sx4YbzViaqoRnVFNtVTrimWBZOSplbkeJD9vyMhPUMo_JyuQJ2XeNM08JZDpB1Kcpor1YKlXGaUw1zzmVwqOZAYm3Uit0x2uO4zXmhY9vUNBFEHSBgi42gh6QN7st3zakHv9afIaqsFuIfNzhRrOYFZ15F5pxbbnOPHjiLFOpzLX10LOkljOeWjkgx1tFKrY6XlBkVqLcR3wD8nL32Js35mykM80qrPEBYZJzMSCip4C9H9R_4qrrQBSe44SxnD77753PyX18E6Gmjh-T_XaxMi88CGvVkBycja8-fxmGQwx__TgdDYO5_QEf7T-6
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtNAEF6V9AAXBBRESoFBAg5Ips56vWsfEGohVUrbCKFW6s2sd9dppHpdEkcoN16Dl-BBeAyehJ2NnTSX3nrJwV7_RDM7_mZ35vsIeS10yJC1JVAhl9iSI4K8iGL3E4Y6iYw0nnbxZMgHZ-zLeXy-Qf60vTBYVtnGRB-odaVwjXyXIg0N5Q4ef7z6EaBqFO6uthIaC7c4MvOfLmWbfjj87Oz7htKD_umnQdCoCgSKibAOZCGwgydPcuxA0yo03CjG4jiPeEIVVUUe93giWKJ7WqZFL3IZRaoTQQvm4IKO3H3vkE0WuVSmQzb3-8Ov39rY77IDJhZ7py71S3cLmxvc8aD0fRoLgSIW175-XiRgDdmu12Ve-9AdPCD3G4QKewuXekg2jH1Etvasy87LObwFXzPqF-O3yN8-MlBINYcVazhUBfgCeDmtA2MvfIkBlHJksV8SXHpfIcmHgXHpFZJgbKGVaanRUdyh0eW4KiVg7wuUppbY9uSurWdlNcH7O9QKOYpbgLQajK8jXD58XE9BrrwOcKkZGv7Y6b9fv8FzeDYxH_DDjsMek7NbseMT0rGVNU8JJCpCYKkoAspQ5rkO45AqnnIqhQNMXRK2VstUQ52OCh6XmUuh0NCZN3SGhs4Whu6Sd8tLrha8ITcN3kdXWA5Eym9_oJqMsiaCZIpxVXCVOHzGWZLHMlWFQ7eaFpzxuJBdstM6UtbEoWm2mjVd8mp52kUQ3BaS1lQzP8blnFHKRZeINQdce6H1M3Z84bnIUxQxS-n2zQ9_Se4OTk-Os-PD4dEzcg__uq_T4zukU09m5rkDdnX-oplNQL7f9gT-DzcsatA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtNAEF6VVEJcEFAQgQKDBByQTJy1vWsfEGppopZCVCEq9WbW6900Um2XxBHKjdfgVXgEHoMnYWZjJ82lt15ysNc_0czOfuOd-T7GXsncD4m1xdO-UNSSI73MBhH--H4eB0YZR7v4ZSQOT8NPZ9HZFvvT9sJQWWUbE12gzitN38h7nGhouEB43LNNWcTJwfDD5Q-PFKRop7WV01i6yLFZ_MT0bfb-6ABt_Zrz4eDbx0OvURjwdCj92lNWUjdPFmfUjZZr3wijwzCKskDEXHNts6gvYhnGeT9Xie0HmF0keSy5DRE65AHe9xbblpgV-R22vT8YnXxt1wHMFEK53EfFNDDp2TIztPvB-bskkpIELa6shE4wYAPlbtZoXln0hvfY3Qatwt7Sve6zLVM-YDt7JWbqxQLegKsfdR_md9jfAbFRKL2ANYM4VBZcMbya1Z4pz125ARRqXFLvJGCqXxHhh4FJ4dSSYFJCK9lSk9PgofHFpCoUUB8MFKZW1AKF19bzoprS_RHBQkZCF6DKHIyrKVw9fFLPQK09EOizMzRcsrN_v36D4_Ns4j_QIk_DHrLTG7HjI9Ypq9I8ZhDrgECm5gQufZVluR_5XItEcCURPHWZ31ot1Q2NOql5XKSYTpGhU2folAydLg3dZW9Xl1wuOUSuG7xPrrAaSPTf7kA1HadNNEl1KLQVOkasJsI4i1SiLSLdnFsRisiqLtttHSltYtIsXc-gLnu5Oo3RhLaIVGmquRuD-WeQCNllcsMBN15o80w5OXe85AkJmiX8yfUPf8Fu48RNPx-Njp-yO_TPXcme2GWdejo3zxDj1dnzZjIB-37T8_c_nLNvBQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Efficacy+evaluation+of+contrast-enhanced+magnetic+resonance+imaging+in+differentiating+glioma+from+metastatic+tumor+of+the+brain+and+exploration+of+its+association+with+patients%E2%80%99+neurological+function&rft.jtitle=Frontiers+in+behavioral+neuroscience&rft.au=Shi%2C+Zhuo&rft.au=Jiang%2C+Jiuming&rft.au=Xie%2C+Lizhi&rft.au=Zhao%2C+Xinming&rft.date=2022-09-06&rft.pub=Frontiers+Media+S.A&rft.eissn=1662-5153&rft.volume=16&rft_id=info:doi/10.3389%2Ffnbeh.2022.957795&rft.externalDocID=PMC9486092
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1662-5153&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1662-5153&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1662-5153&client=summon